Digitally quantified CD8(+) cells: the best candidate marker for an immune cell score in non-small cell lung cancer?

The TNM classification is well established as a state-of-the-art prognostic and treatment-decision-making tool for non-small cell lung cancer (NSCLC) patients. However, incorporation of biological data may hone the TNM system. This article focuses on choosing and incorporating subsets of tissue-infi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kilvaer, Thomas K, Paulsen, Erna-Elise, Andersen, Sigve, Rakaee, Mehrdad, Bremnes, Roy M, Busund, Lill-Tove Rasmussen, Donnem, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Cancer Biomarkers and Molecular Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791621/
https://www.ncbi.nlm.nih.gov/pubmed/33035322
http://dx.doi.org/10.1093/carcin/bgaa105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791621/
https://www.ncbi.nlm.nih.gov/pubmed/33035322
http://dx.doi.org/10.1093/carcin/bgaa105

Ejemplares similares